SCHEDULE: Intracoastal Capital Discloses 8.2% Stake in Microbot Medical

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a passive beneficial ownership of 8.2% in Microbot Medical Inc. common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed a Schedule 13G regarding their beneficial ownership in Microbot Medical Inc.
• The Reporting Persons collectively beneficially own 6,002,185 shares of Microbot Medical Inc. common stock.
• This ownership represents approximately 8.2% of the company's common stock.
• The beneficial ownership is primarily derived from shares issuable upon the exercise of a warrant held by Intracoastal Capital LLC (the "Intracoastal Warrant").
• The percentage is calculated based on 67,158,044 shares of common stock outstanding as of November 14, 2025, as reported by Microbot Medical Inc., plus the 6,002,185 shares issuable from the Intracoastal Warrant.
• The Reporting Persons hold shared voting power and shared dispositive power over all 6,002,185 beneficially owned shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, indicating a passive investment.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual disclosure of passive ownership and does not contain operational or financial performance updates. The presence of a significant institutional stake could be interpreted positively by some investors.

Positives

• A significant institutional investor group, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, holds a substantial 8.2% stake in Microbot Medical Inc., which can be viewed as a vote of confidence in the company's long-term prospects.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant passive ownership stake by an institutional investor group. It does not provide specific insights into Microbot Medical Inc.'s operational performance or strategic direction, nor does it directly relate to broader industry trends beyond indicating investor interest in the medical device or robotics sector, where Microbot Medical operates.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which may influence market perception and investor confidence.
• Management: Awareness of a substantial passive investor group holding 8.2% of the company's common stock.

Key Dates

Keywords

Microbot Medical Inc., Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, beneficial ownership, common stock, institutional ownership, passive investment, warrant